Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
33%(4 trials)

Phase Distribution

Ph phase_2
6
46%
Ph phase_1
2
15%
Ph phase_4
1
8%
Ph not_applicable
2
15%

Phase Distribution

2

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
6(54.5%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(12)
Other(1)

Detailed Status

Completed12
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (18.2%)
Phase 26 (54.5%)
Phase 41 (9.1%)
N/A2 (18.2%)

Trials by Status

unknown18%
completed1292%

Recent Activity

0 active trials
Showing 5 of 13
completedphase_2

Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors

NCT05662852
completedphase_1

A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants

NCT05827874
completed

Pertussis Immunization During Pregnancy & HIV Infection

NCT03519373
completednot_applicable

Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults

NCT02261961
completedphase_2

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

NCT04071158
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05662852Phase 2

Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors

Completed
NCT05827874Phase 1

A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants

Completed
NCT03519373

Pertussis Immunization During Pregnancy & HIV Infection

Completed
NCT02261961Not Applicable

Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults

Completed
NCT04071158Phase 2

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Completed
NCT00553228Phase 2

Pertussis Maternal Immunization Study

Completed
NCT03313050Phase 2

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

Completed
NCT02301702Phase 2

Maternal Tdap Immunization in Guatemala

Completed
NCT02955160Phase 1

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Completed
NCT03304275Not Applicable

The Feasibility of Pertussis Immunization in a Canadian Emergency Department

Completed
NCT02209623

TDAP Safety in Pregnant Women

Completed
NCT02825368Phase 4

Homeopathic Vaccine Trial

Unknown
NCT01367158Phase 2

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

Completed

All 13 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
13